Showing results (1401-1410 of 1,488) with videos related to

Sort By:
Pageof 149
Anesthesia and Analgesia|April 16, 2021
The Society for Obstetric Anesthesia and Perinatology Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With ThrombocytopeniaMelissa E Bauer, Katherine Arendt, Yaakov Beilin, et al.
Journal of the Pediatric Infectious Diseases Society|October 9, 2023
Pediatric Infectious Diseases Milestones: A Step in the Right Direction to Evaluate Subspecialty LearnersSanya J Thomas, Marsha S Anderson, Elisabeth E Adderson, et al.
Breast Cancer Research and Treatment|April 27, 2012
Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressorElizabeth Iorns, Toby M Ward, Sonja Dean, et al.
Plos One|November 18, 2021
Development and validation of a prognostic tool: Pulmonary embolism short-term clinical outcomes risk estimation (PE-SCORE)Anthony J Weekes, Jaron D Raper, Kathryn Lupez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 17, 2025
Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term ProphylaxisMarc A Riedl, Jonathan A Bernstein, Joshua S Jacobs, et al.
Physical Review Letters|July 10, 2026
Low-Energy Dipole Strength Distribution in ^{102}Ru: Coexistence of Scissors and Octupole ResonancesA Saracino, A D Ayangeakaa, Q B Chen, et al.
Journal of Thrombosis and Thrombolysis|November 18, 2006
The U.S. Thrombosis and Hemostasis Centers pilot sites programN F Dowling, M G Beckman, M Manco-Johnson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 18, 2021
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)H James Wedner, Emel Aygören-Pürsün, Jonathan Bernstein, et al.
Allergy|March 14, 2026
Switching Long-Term Prophylaxis to Donidalorsen for Hereditary Angioedema: 1-Year OASISplus ResultsMarc A Riedl, Jonathan A Bernstein, Joshua S Jacobs, et al.
Antiviral Research|December 13, 2022
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirusAndrea J Parsons, Sabrina I Ophir, Thomas J Gardner, et al.
Pageof 149